Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DXR24U
|
||||
| Drug Name |
(S)-1-[4-(4,6-Dimethyl-benzo[b]thiophen-2-yl)-piperidin-1-yl]-3-(1H-indol-4-yloxy)-propan-2-ol
|
||||
| Synonyms |
CHEMBL56471
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C26H30N2O2S
|
||||
| Canonical SMILES |
Cc1cc(C)c2cc(sc2c1)C3CCN(C[C@H](O)COc4cccc5[nH]ccc45)CC3
|
||||
| InChI |
InChI=1S/C26H30N2O2S/c1-17-12-18(2)22-14-25(31-26(22)13-17)19-7-10-28(11-8-19)15-20(29)16-30-24-5-3-4-23-21(24)6-9-27-23/h3-6,9,12-14,19-20,27,29H,7-8,10-11,15-16H2,1-2H3/t20-/m0/s1
|
||||
| InChIKey |
URRZGKMZPRCQHM-FQEVSTJZSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | 5-hydroxytryptamine 1A receptor | Target Info | [1587926] | ||
| Sodium-dependent serotonin transporter | Target Info | [1587926] | |||
| NetPath Pathway | TCR Signaling Pathway | ||||
| PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
| 5HT1 type receptor mediated signaling pathwayP04373:5HT1 type receptor mediated signaling pathway | |||||
| 5HT2 type receptor mediated signaling pathway | |||||
| 5HT3 type receptor mediated signaling pathway | |||||
| 5HT4 type receptor mediated signaling pathway | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.